[{"indications": "Indications\u00a0raised intra-ocular pressure, see notes above", "name": "BRIMONIDINE TARTRATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.6 Treatment of glaucoma", "Sympathomimetics"], "cautions": "Cautions\u00a0severe cardiovascular disease; cerebral or coronary\r\ninsufficiency, Raynaud\u2019s syndrome, thromboangiitis obliterans, postural hypotension, depression; children 2\u201312 years (increased risk of drowsiness); interactions: Appendix 1 (brimonidine)Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving)", "side-effects": "Side-effects\u00a0dry mouth, gastro-intestinal disturbances, taste\r\ndisturbances, upper respiratory symptoms, headache, drowsiness, dizziness,\r\nmalaise, ocular disturbances (including hyperaemia, burning, stinging,\r\npruritus, pain and dryness), visual disturbances, eyelid inflammation,\r\nphotophobia, corneal erosion and staining, conjunctival disturbances\r\n(including blanching, follicles, and infection); less commonly palpitation, arrhythmia, bradycardia, tachycardia, depression, nasal\r\ndryness; rarely dyspnoea; very rarely hypertension, hypotension, syncope, insomnia, iritis, miosis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/59167.htm", "doses": ["Apply twice daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if benefit outweighs\r\nrisk"}, {"indications": "Indications\u00a0raised intra-ocular pressure, see notes above", "name": "BRIMONIDINE TARTRATE With timolol", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "11 Eye", "11.6 Treatment of glaucoma", "Sympathomimetics", "BRIMONIDINE TARTRATE", "With timolol"], "cautions": "Cautions\u00a0severe cardiovascular disease; cerebral or coronary\r\ninsufficiency, Raynaud\u2019s syndrome, thromboangiitis obliterans, postural hypotension, depression; children 2\u201312 years (increased risk of drowsiness); interactions: Appendix 1 (brimonidine)Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving)", "side-effects": "Side-effects\u00a0dry mouth, gastro-intestinal disturbances, taste\r\ndisturbances, upper respiratory symptoms, headache, drowsiness, dizziness,\r\nmalaise, ocular disturbances (including hyperaemia, burning, stinging,\r\npruritus, pain and dryness), visual disturbances, eyelid inflammation,\r\nphotophobia, corneal erosion and staining, conjunctival disturbances\r\n(including blanching, follicles, and infection); less commonly palpitation, arrhythmia, bradycardia, tachycardia, depression, nasal\r\ndryness; rarely dyspnoea; very rarely hypertension, hypotension, syncope, insomnia, iritis, miosis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129337.htm", "doses": ["Apply twice daily", "Name[Combigan\u00ae (Allergan) ] Eye drops, brimonidine tartrate\r\n0.2%, timolol (as maleate) 0.5%, net price 5-mL = \u00a310.00Excipients  include benzalkonium chlorideDose\u00a0for raised intra-ocular pressure in open-angle glaucoma\r\nand for ocular hypertension when beta-blocker alone not adequate,\r\napply twice daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if benefit outweighs\r\nrisk"}]